Document |
Document Title |
WO/1998/050344A1 |
Substituted cyanoenamines of general formula (I) wherein Z, R?1�, R?2� and R?3� are defined in the description, compositions thereof and methods for preparing the compounds are described. The compounds are useful in the treatment o...
|
WO/1998/050358A1 |
Compounds of formula (I), processes for their preparation and their use as CNS agents are disclosed, in which R?a� is a group of formula (i), in which P?1� is phenyl, bicyclic aryl, a 5- to 7-membered heterocyclic ring containing 1 t...
|
WO/1998/048800A1 |
This application relates to novel compounds of formula (I), and their pharmaceutically acceptable salts, as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of ...
|
WO/1998/049157A1 |
This invention concerns compounds of formula (I), the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein the dotted line represents an optional bond; X is oxygen or sulfur; R?1� and...
|
WO/1998/047933A1 |
Provided are certain transition metal complexes which are useful as catalysts in the polymerization of olefinic monomers. In particular, the invention provides complexes of certain bidentate ligands bonded to Ni, Pd, Co, or Fe, and optio...
|
WO/1998/047882A1 |
The present invention provides a compound of formula (I), wherein ring A is an optionally substituted aromatic hydrocarbon ring or aromatic heterocyclic ring; ring B is an optionally substituted aromatic hydrocarbon ring or aromatic hete...
|
WO/1998/045275A1 |
Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. A preferred aspect of the invention are compounds of Formula (II) in which: the dashed lines...
|
WO/1998/045290A1 |
2-Aminothiazoleacetic acid derivatives of general formula (I), wherein R?1�, X and Y are each a specified organic group. These compounds are particularly useful for the acylation of some cephalosporin antibiotics.
|
WO/1998/043969A1 |
The present invention describes indazoles of cyclic ureas of formula (I): wherein X is a linker group and Y may be acyclic or cyclic, which are useful as inhibitors of HIV protease, and pharmaceutical compositions and diagnostic kits com...
|
WO/1998/043956A1 |
Novel 1,4-substituted cyclic amine derivatives which have serotonin antagonism and serve as drugs having high clinical usefulness, especially an agent for the remedy/alleviation/prevention of spastic paralysis or a central muscle relaxan...
|
WO/1998/043970A1 |
A quaternized nitrogen-containing imidazol-1-yl or 1,2,4-triazol-1-yl compound wherein one of nitrogen atoms constituting an azole ring is quaternized with a substituent capable of being eliminated $i(in vivo) and the substituent can be ...
|
WO/1998/042678A1 |
1-Alkyl-4-benzoyl-5-hydroxy-1H-pyrazole compounds in which the benzoyl moiety is substituted in the 2-position with groups such as halo or alkyl, in the 4-position with an alkylsulfonyl group, and in the 3-position with a cyclic or acycl...
|
WO/1998/041510A1 |
Compounds represented by general formula (I), pharmaceutically acceptable salts thereof, or hydrates of these; pharmaceutical compositions comprising the same; a method for inhibiting feeding characterized by administering the same; a me...
|
WO/1998/040420A2 |
The present invention includes novel ligands which may be utilized as part of a catalyst system. A catalyst system of the present invention is a transition metal-ligand complex. In particular, the catalyst system includes a transition me...
|
WO/1998/040361A1 |
Aminosulfonylureas of general formula (I). The aminosulfonylureas of said formula are endowed with a high herbicidal activity against numerous weeds.
|
WO/1998/040374A2 |
Methods for preparing olefin polymers, or oligomers catalysts for preparing olefin polymers and bidentate ligand used for preparing these catalysts are disclosed. The polymers can be prepared containing the corresponding monomers with a ...
|
WO/1998/039303A1 |
A method treating or preventing inflammatory and immune cell-mediated diseases by the administration of certain novel and known small molecules. Exemplary of the novel compounds are those of structural formulas (a), (b), (c), (d), (e) an...
|
WO/1998/039305A1 |
Form II crystals having a melting point of 127 �C � 3 �C, of the compound represented by formula (I) are low in hygroscopicity and excellent in stability.
|
WO/1998/038172A1 |
The invention relates to new phenyl-amino-sulfonyl-urea derivatives, a method for producing said derivatives, and the use thereof as fungicides.
|
WO/1998/038167A1 |
Compounds of formula (I) wherein R?1� is optionally substituted (C�2?-C�9?)heteroaryl; R?2� is optionally substituted phenyl-(CH�2?)�m?-, naphthyl-(CH�2?)�m?-, (C�3?-C�10?)cycloalkyl-(CH�2?)�m?-, (C�1?-C�6?)al...
|
WO/1998/038168A1 |
An isoquinolinone derivative of formula (I) wherein Ring A and Ring B are substituted or unsubstituted benzene, R?1� is (1) H, (2) substituted or unsubstituted lower alkyl, (3) substituted or unsubstituted cyclo-lower alkyl, (4) substi...
|
WO/1998/037079A1 |
$i(N)-Heterocyclic derivatives of formula (I) are described herein, as well as other $i(N)-Heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as ...
|
WO/1998/037070A1 |
Novel compounds which are compounds represented by general formula (I) or salts thereof having a steroid C�17-20? lyase inhibitory activity and being useful as preventives or remedies for tumors such as prostatism and mammary cancer. I...
|
WO/1998/035937A1 |
CETP activity inhitors containing as the active ingredient compounds represented by general formula (I), prodrug compounds thereof, pharmaceutically acceptable salts thereof, or hydrates or solvates of these, (wherein R represents linear...
|
WO/1998/035954A1 |
Compounds of Formula (I), and their $i(N)-oxides and agriculturally suitable salts, are disclosed which are useful for controlling undesired vegetation wherein Q is Q-1, Q-2, Q-3 or Q-4; and Q, Z, X, R?1� through R?20�, m, n, and r a...
|
WO/1998/034921A1 |
The present invention provides compounds of Formula (I). The present invention also provides a method of treating cancer and treating or preventing restenosis or atherosclerosis. Also provided by the present invention is a pharmaceutical...
|
WO/1998/034923A1 |
A class of 1-phenylbenzimidazole derivatives, substituted at the $i(meta) position of the phenyl ring by a methylene-, carbonyl- or thiocarbonyl-linked amine moiety, are selective ligands for GABA�A? receptors, in particular having hig...
|
WO/1998/034934A1 |
The present invention concerns novel compounds of formula (I), the $i(N)-oxide forms, the pharmaceutically acceptable addition salts thereof and stereochemically isomeric forms thereof, wherein -A-B- forms a bivalent radical of formula -...
|
WO/1998/033778A1 |
Triazole compounds represented by general formula (I) and excellent as an antimycotic, wherein Ar?1� represents a phenyl group which may be substituted, Ar?2� represents a naphthyl group which may be substituted, R?1� represents a ...
|
WO/1998/032744A1 |
The invention herein relates to a process for the manufacture of fluconazole, or more particularly, to the process for the manufacture of fluconazole of Formula (1) having superior antifungal activity with a high yield and purity, and it...
|
WO/1998/032741A1 |
The present invention relates to inhibitors of ras farnesylation of Formula (I), wherein T is of Formula (1) or (2) or (3); A is aryl or heteroaryl; B is aryl or heteroaryl; X and Y represent hydrogen, or both X and Y can represent a sin...
|
WO/1998/032743A1 |
The invention concerns compounds of formula (I) and their salts, in the formula R?1�-R?9�, W and A being defined as in formula (I) according to claim 1. These compounds and salts are suitable as herbicides and plant-growth regulators...
|
WO/1998/032740A1 |
A process for producing optically active 4-[$g(a)-hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimeth
ylbenzoic acid or pharmacologically acceptable salts thereof which comprises optically resolving compounds represented by general formu...
|
WO/1998/031672A1 |
Describes a method of producing N,N'-diazole compounds, e.g. N,N'-carbonyldiimidazole, by reacting in an inert solvent, e.g., toluene, a 1-unsubstituted 1H-azole compound, e.g., 1H-imidazole, and a dihalide compound, e.g., phosgene, in t...
|
WO/1998/031675A1 |
A compound of formula (I), or an optical isomer or pharmaceutically acceptable salt thereof, is disclosed as well as a pharmaceutical composition and a method of treating or preventing a fungal infection using the compound.
|
WO/1998/030558A2 |
Novel tricyclic compounds of Formula (1.0) are disclosed. Compounds of Formula (1.0) are represented by the compounds of formulas (1.4) or (1.5) wherein R?1�, R?3� and R?4� are each independently selected from halo. Also disclosed ...
|
WO/1998/028269A1 |
The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula (I) or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is N or NH and D may be C(=NH)NH�2?, which are useful ...
|
WO/1998/028257A1 |
Compounds represented by general formula (1) which have NOS inhibitory activities and are useful as drugs, for example, remedies for cerebrovascular disorders, wherein R�1? and R�2? represent each hydrogen, etc.; R�3? and R�4? re...
|
WO/1998/027059A1 |
Compounds represented by general formula (I) or pharmaceutically acceptable salts thereof and a process for producing the same. Because of having an inhibitory activity on the bonding of progesterone to its receptor, these compounds are ...
|
WO/1998/027108A2 |
A compound of formula (I) wherein each symbol is as defined in the specification, and pharmaceutically acceptable salts thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof possess a strong inh...
|
WO/1998/027086A1 |
The present invention relates to novel heterocyclic substituted pyrrolidine amide derivatives of formula (1), and stereoisomers and pharmaceutically acceptable salts thereof and their use as tachykinin receptor antagonists. Such antagoni...
|
WO/1998/025883A1 |
The invention concerns ketobenzamides of formula (I) in which R?1�, R?2�, R?3�, R?4�, X and n have the meanings given in the description. The invention further concerns their preparation. The novel compounds are suitable for comb...
|
WO/1998/025467A1 |
The invention concerns novel substituted thienyl(amino)sulphonyl(thio)ureas of formula (I), in which A stands for nitrogen or a CH group; E stands for a single bond or an NH group; Q stands for oxygen or sulphur; R?1� and R?2�, indep...
|
WO/1998/025912A1 |
Compounds for Formula (I), and their $i(N)-oxides and agriculturally suitable salts, are disclosed which are useful for controlling undesired vegetation wherein A, W, R?1�, R?2�, R?3�, and m are as defined in the disclosure. Also d...
|
WO/1998/024771A1 |
This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc. and represented by general formula (I) wherein R?1� is aryl optionally substituted with lower alkoxy, etc., R?2� is lower alkyl, etc...
|
WO/1998/024785A1 |
A compound of formula (I) wherein R?1� and R?2� are each hydrogen or linked together to form ethylene, R?3� is hydrogen or lower alkyl, R?4� is heterocyclic group, R?5� is hydrogen or nitro, and X is CH or N, and pharmaceutical...
|
WO/1998/023597A1 |
Novel 4,5-diamino pyrimidine derivatives having the inhibitory activity of cyclic guanosine 3',5'-monophosphate phosphodiesterase and tumor necrosis factor, physiologically acceptable salt, solvate or metabolically readily conversible es...
|
WO/1998/021963A1 |
Novel agrichemical quaternary salts, compositions and a method to prepare them are disclosed.
|
WO/1998/021204A1 |
A method of preparation of optically pure isomers of hydroxyitraconazole, in particular the two $i(cis) dioxolane diastereomers of the $i(sec)-butyl (S,S)-isomer, and to phosphate and sulfate derivatives thereof is disclosed. Pharmaceuti...
|
WO/1998/021186A1 |
The present invention is directed to novel benzothiazo and related heterocyclic group-containing inhibitors of cysteine or serine proteases. Methods for using the same are also described.
|